Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. Several other research analysts have also issued reports on the stock. Wells Fargo & Company set a $51.00 target price on shares of Rapport [...]
Rapport Therapeutics (NASDAQ:RAPP) Downgraded to Sell Rating by Wall Street Zen
